- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0002572

About Symbiotic Therapeutics Private Limited
Data last updated:
Symbiotic Therapeutics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51109DL2000PTC106441. Its GSTIN is 02AAECS8069A1ZN (Himachal Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was formerly known as Symbiotic Drugs & Diabetic Care Private Limited. It is led by directors Bhupender Kaushal and Sanjay Guleria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 305 Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2026, the company reported a revenue of ₹29.86 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹1.67 Cr (net margin 5.6%) and EBITDA of ₹2.47 Cr (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.
The company has about 184 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹95 Lakh and satisfied charges of ₹2.2 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.
Symbiotic Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002572). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symbiotictherapeutics.com.
Company details
Recognitions & Rankings of Symbiotic Therapeutics
Contact details
Symbiotic Therapeutics Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address305 Mahajan Tower Plot No 7 L.Sc Shreshtha Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Symbiotic Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Symbiotic Therapeutics is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Symbiotic Therapeutics Private Limited, buy the company report.
Financials of Symbiotic Therapeutics Private Limited
FY 2026 filings availableSymbiotic Therapeutics Private Limited reported revenue of ₹29.86 Cr (up 13% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 13% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹29.86 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symbiotic Therapeutics Private Limited, buy the company report.
Board of directors of Symbiotic Therapeutics Private Limited
Symbiotic Therapeutics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupender Kaushal | Director | 23 Jun 2000 | 26 Years 4 Months | Current |
| Sanjay Guleria | Director | 23 Jun 2000 | 26 Years 4 Months | Current |
Auditor
Symbiotic Therapeutics Private Limited is audited by NAVEEN KUMAR & ASSOCIATES for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAVEEN KUMAR & ASSOCIATES | FY 2026 | 006322C |
Shareholding
The shareholding of Symbiotic Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Symbiotic Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2005 | 90059057 | Punjab National Bank | ₹95 Lakh | Open | |
| 20 Jun 2019 | 100271363 | Others | ₹25 Lakh | Satisfied | |
| 26 Oct 2018 | 100224139 | Others | ₹10 Lakh | Satisfied | |
| 30 Jan 2013 | 10402647 | Punjab National Bank | ₹8.5 Lakh | Satisfied | |
| 08 Aug 2008 | 10117355 | Member Secretary | ₹15.09 Lakh | Satisfied |
To see the full charge records of Symbiotic Therapeutics Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Symbiotic Therapeutics Private Limited has 4 court cases on record: 4 filed by Symbiotic Therapeutics. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Commercial suit | Filed by the company against Ulkas Fertichem Private Limited | Disposed |
| District court, Shahdara, Delhi | Civil suit | Filed by the company against an individual | Pending |
| District court, Solan, Himachal Pradesh | Civil suit | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Disposed |
To see the full case history of Symbiotic Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Symbiotic Therapeutics Private Limited was last rated by Crisil on 14 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 14 Jun 2020 |
To see the full credit ratings and regulatory alerts of Symbiotic Therapeutics Private Limited, buy the company report.
MSME payment delays
Symbiotic Therapeutics Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 708 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 27)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alex Packaging Private Limited | |||
| Sunplen Packaging | |||
| Symbiosis Pharmaceuticals Private Limited | |||
| MDC Pharmaceuticals Limited | |||
| Nav Foils Pak |
To see the full MSME payment records of Symbiotic Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Symbiotic Therapeutics Private Limited has a workforce of 184 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 184 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Symbiotic Therapeutics Private Limited, buy the company report.
GST
Symbiotic Therapeutics has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAECS8069A1ZN | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Symbiotic Therapeutics Private Limited, buy the company report.
Recent activity
Symbiotic Therapeutics Private Limited has 4 board changes on record since 2000: 2 appointments and 2 cessations. The latest: Babita Guleria ceased to be Director on 01 Aug 2009.
13 earlier events are in the company report.
Frequently asked questions
Symbiotic Therapeutics is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2000 (26+ years old) and is registered under CIN U51109DL2000PTC106441.
Symbiotic Therapeutics has 2 current directors:
- Bhupender Kaushal - Director
- Sanjay Guleria - Director
The latest financial statements of Symbiotic Therapeutics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Symbiotic Therapeutics is 02AAECS8069A1ZN, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Symbiotic Therapeutics is U51109DL2000PTC106441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symbiotic Therapeutics has 4 court cases on record: 4 filed by the company. 2 are pending.
Symbiotic Therapeutics was incorporated on 23 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
Babita Guleria ceased to be Director on 01 Aug 2009. Kalpana Kaushal ceased to be Director on 01 Aug 2009. Bhupender Kaushal was appointed as Director on 23 Jun 2000. Symbiotic Therapeutics has 4 board changes on record in total.
Yes, Symbiotic Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0002572).
Symbiotic Therapeutics has 13 MSME Form 1 returns on record between 2019 and 2023, listing 708 overdue payments to 27 micro and small suppliers. The latest return was filed on 04 Jan 2024.
Symbiotic Therapeutics can be reached through the website symbiotictherapeutics.com. Its registered office is in New Delhi, Delhi, India.

